India's Novartis ruling: the implications for patent owners

03-04-2013

India's Novartis ruling: the implications for patent owners

Image: Novartis AG

India’s Supreme Court has rejected pharmaceutical company Novartis’s application to patent an updated version of its leukaemia drug Glivec, agreeing with the Comptroller General that it lacked novelty.


India, Novartis, patent, Supreme Court, ruling

More on this story

IPAB rejects Monsanto plant patent
15-07-2013

LSIPR